- Home
- MIRM vs RUM Comparison
MIRM vs RUM Comparison
Compare MIRM & RUM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MIRM
- RUM
- Stock Information
- Founded
- MIRM 2018
- RUM 2013
- Country
- MIRM United States
- RUM United States
- Employees
- MIRM N/A
- RUM N/A
- Industry
- MIRM Biotechnology: Pharmaceutical Preparations
- RUM Computer Software: Prepackaged Software
- Sector
- MIRM Health Care
- RUM Technology
- Exchange
- MIRM Nasdaq
- RUM Nasdaq
- Market Cap
- MIRM 3.3B
- RUM 2.7B
- IPO Year
- MIRM 2019
- RUM N/A
- Fundamental
- Price
- MIRM $67.93
- RUM $7.90
- Analyst Decision
- MIRM Strong Buy
- RUM Buy
- Analyst Count
- MIRM 9
- RUM 2
- Target Price
- MIRM $73.89
- RUM $15.00
- AVG Volume (30 Days)
- MIRM 661.2K
- RUM 3.2M
- Earning Date
- MIRM 08-06-2025
- RUM 08-11-2025
- Dividend Yield
- MIRM N/A
- RUM N/A
- EPS Growth
- MIRM N/A
- RUM N/A
- EPS
- MIRM N/A
- RUM N/A
- Revenue
- MIRM $429,161,000.00
- RUM $104,076,612.00
- Revenue This Year
- MIRM $36.76
- RUM $19.22
- Revenue Next Year
- MIRM $17.48
- RUM $36.85
- P/E Ratio
- MIRM N/A
- RUM N/A
- Revenue Growth
- MIRM 62.33
- RUM 32.45
- 52 Week Low
- MIRM $36.86
- RUM $4.92
- 52 Week High
- MIRM $69.00
- RUM $17.40
- Technical
- Relative Strength Index (RSI)
- MIRM 82.95
- RUM 40.10
- Support Level
- MIRM $50.25
- RUM $7.84
- Resistance Level
- MIRM $67.45
- RUM $8.51
- Average True Range (ATR)
- MIRM 2.89
- RUM 0.44
- MACD
- MIRM 1.38
- RUM -0.05
- Stochastic Oscillator
- MIRM 94.29
- RUM 6.83
About MIRM Mirum Pharmaceuticals Inc.
Mirum Pharmaceuticals Inc is a biopharmaceutical company focused on the identification, acquisition, development, and commercialization of novel therapies for debilitating rare and orphan diseases. Its product, Livmarli, a novel, orally administered, minimally-absorbed ileal bile acid transporter IBAT) inhibitor (IBATi), is approved for the treatment of cholestatic pruritus in patients with Alagille syndrome (ALGS). It is involved in the development of Maralixibat for the treatment of pediatric patients with progressive familial intrahepatic cholestasis, or PFIC, and Alagille syndrome, or ALGS. The company is also involved in the development of volixibat for the treatment of adult patients with cholestatic liver diseases.
About RUM Rumble Inc.
Rumble Inc is a free-to-use video-sharing platform where users can watch, share, like, comment, and upload their own videos. Users can subscribe to channels to stay in touch with recent creator content and access video-on-demand uploaded, and live content streamed, by creators. Geographically, it generates a majority of its revenue from the United States.